Despite the remarkable findings from in vivo animal models of Fli1 deletion and skin fibrosis, the expression pattern of Fli1 in patients with SSc has not been well characterized, and it is unclear which cell types show a reduction in Fli1 expression leading to the development of fibrosis in patients with SSc. The gene discussed is FLI1; the disease is systemic sclerosis.